Obesity may reduce efficacy of psoriasis therapies
Psoriasis is strongly associated with obesity, which can reduce the efficacy of biologic and conventional therapies, increase side effects, and affect drug survival. An expert panel reviewed available evidence and developed consensus recommendations to optimize care for this population. Weight control is an essential component of psoriasis management, alongside expanding therapeutic options.



